About the Company
wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $WVE News
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
INHBE lead clinical candidate selected; potential best-in-class treatment for obesity with potent and durable silencing, ...
Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2023 Earnings Call Transcript
Q4 2023 Earnings Call Transcript March 6, 2024 Wave Life Sciences Ltd. isn’t one of the 30 most popular stocks among hedge ...
Wave Life Sciences Gains 34% On Narrower Loss In Q4
Shares of Wave Life Sciences Ltd. (WVE) are gaining more than 34 percent on Wednesday morning after reporting narrower net loss in ...
Wave Life Sciences: Q4 Earnings Snapshot
SINGAPORE — SINGAPORE — Wave Life Sciences Pte. Ltd. (WVE) on Wednesday reported a loss of $16.3 million in its fourth quarter. The Singapore-based company said it had a loss of 15 cents per share.
Wave Life Sciences Ltd earnings beat by $0.08, revenue topped estimates
Investing.com - Wave Life Sciences Ltd (NASDAQ: WVE) reported first quarter EPS of $-0.150, $0.08 better than the analyst estimate of $-0.230. Revenue for the quarter came in at $29.06M versus the ...
Wave Life Sciences Ltd. (WVE) Q4 2023 Earnings Call Transcript
Good morning, and welcome to Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. As a reminder ...
Wave Life Sciences: Q4 Earnings Snapshot
SINGAPORE (AP) — SINGAPORE (AP) — Wave Life Sciences Pte. Ltd. (WVE) on Wednesday reported a loss of $16.3 million in its fourth quarter. The Singapore-based company said it had a loss of 15 ...
Loading the latest forecasts...